Agilent Technologies A
NYSE A
$156.34 +2.65 (+1.72%)
As of: Sep 17, 2026 · 3:59 PM EDT

Agilent Technologies (A) Liabilities and Shareholders Equity (2009 - 2026)

Agilent Technologies' (A) quarterly Liabilities and Shareholders Equity came in at $14.0 billion in Q3 2026, up 14.24% year-over-year from $12.2 billion in Q3 2025, and up 6.9% quarter-over-quarter from $13.1 billion in Q2 2026.

Analysis

Agilent Technologies (A) Liabilities and Shareholders Equity (2009 - 2026) Analysis & Trends

Agilent Technologies (A) has reported Liabilities and Shareholders Equity for 18 consecutive years, with $14.0 billion the latest figure, recorded in Q3 2026.

  • On a quarterly basis, Liabilities and Shareholders Equity rose 14.24% year-over-year to $14.0 billion in Q3 2026; TTM through Jul 2026 was $52.6 billion, a 9.2% increase from a year earlier, with the FY2025 full-year figure at $12.7 billion, up 7.44% from the prior year.
  • Liabilities and Shareholders Equity was $14.0 billion for Q3 2026 at Agilent Technologies, up from $13.1 billion in the prior quarter.
  • Over five years, Liabilities and Shareholders Equity peaked at $14.0 billion in Q3 2026 and troughed at $10.3 billion in Q1 2022.
  • A 5-year average of $11.5 billion and a median of $10.9 billion in 2024 frame the typical range for Liabilities and Shareholders Equity.
  • Across the five-year window, Liabilities and Shareholders Equity dropped 1.62% in 2022 and gained 14.24% in 2026, its largest moves.
  • Over 5 years, Liabilities and Shareholders Equity stood at $10.5 billion in 2022, then climbed by 2.19% to $10.8 billion in 2023, then advanced by 10.06% to $11.8 billion in 2024, then gained by 7.44% to $12.7 billion in 2025, then climbed by 9.74% to $14.0 billion in 2026.
  • The last three Liabilities and Shareholders Equity figures came in at $14.0 billion (Q3 2026), $13.1 billion (Q2 2026), and $12.8 billion (Q1 2026), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Thermo Fisher Scientific 241.68 Bn 237.61 Bn 8.34 Bn 113.17 Bn
2 Danaher 147.34 Bn 142.99 Bn 3.61 Bn 92.37 Bn
3 Agilent Technologies 43.34 Bn 41.59 Bn 1.04 Bn 13.97 Bn
4 Illumina 34.58 Bn 33.41 Bn 770.00 Mn 6.65 Bn
5 Revvity 16.31 Bn 15.29 Bn 416.87 Mn 12.05 Bn
6 Bio-Techne 11.28 Bn 11.01 Bn 211.39 Mn 2.59 Bn
7 Bio-Rad Laboratories 10.16 Bn 8.54 Bn 345.80 Mn 10.25 Bn
8 Repligen 9.77 Bn 8.75 Bn 110.04 Mn 2.95 Bn
9 10x Genomics 9.45 Bn 8.90 Bn 112.50 Mn 1.03 Bn
10 Bruker 9.26 Bn 9.04 Bn 416.00 Mn 6.05 Bn
Historic Data

Historic Data

Download Data
DateValue
Jul 31, 2026 13.97 Bn
Apr 30, 2026 13.07 Bn
Jan 31, 2026 12.81 Bn
Oct 31, 2025 12.73 Bn
Jul 31, 2025 12.23 Bn
Apr 30, 2025 12.16 Bn
Jan 31, 2025 11.91 Bn
Oct 31, 2024 11.85 Bn
Jul 31, 2024 11.00 Bn
Apr 30, 2024 10.86 Bn
Jan 31, 2024 10.95 Bn
Oct 31, 2023 10.76 Bn
Jul 31, 2023 10.68 Bn
Apr 30, 2023 10.79 Bn
Jan 31, 2023 10.92 Bn
Oct 31, 2022 10.53 Bn
Jul 31, 2022 10.48 Bn
Apr 30, 2022 10.46 Bn
Jan 31, 2022 10.33 Bn
Oct 31, 2021 10.71 Bn